Immunoclin Corp Comprehensive Income
Immunoclin Corp reported Comprehensive Income of -$6.04 million for the 3-month period ending 2014-10-31, per its 10-Q filed 2014-12-22.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2014-12-22
- Immunoclin Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2014-10-31 was -$6.04M.
- Immunoclin Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2014-07-31 was -$1.11M.
- Immunoclin Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2014-04-30 was -$805.92K.
- Immunoclin Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2014-01-31 was -$12.53M.
- Immunoclin Corp comprehensive income (loss), net of tax, attributable to parent for fiscal 2014 was -$13.00M.
- Immunoclin Corp comprehensive income (loss), net of tax, attributable to parent for fiscal 2013 was -$78.53K.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2014-10-31 | -$6.04M 10-Q · filed 2014-12-22 | -$7.15M derived: sum of 2 quarters · filed 2014-12-22 | -$7.95M 10-Q · filed 2014-12-22 | -$20.49M derived: sum of 4 quarters · filed 2014-12-22 |
| 2014-07-31 | -$1.11M 10-Q · filed 2014-09-29 | -$1.92M 10-Q · filed 2014-09-29 | -$14.44M derived: sum of 3 quarters · filed 2014-09-29 | -$14.61M derived: sum of 4 quarters · filed 2014-12-22 |
| 2014-04-30 | -$805.92K 10-Q · filed 2014-07-24 | -$13.34M derived: sum of 2 quarters · filed 2014-07-24 | -$13.50M derived: sum of 3 quarters · filed 2014-12-22 | -$13.68M derived: sum of 4 quarters · filed 2014-12-22 |
| 2014-01-31 | -$12.53M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-07 | -$12.69M derived: sum of 2 quarters · filed 2014-12-22 | -$12.87M derived: sum of 3 quarters · filed 2014-12-22 | -$13.00M 10-K · filed 2014-07-07 |
| 2013-10-31 | -$162.09K 10-Q · filed 2014-12-22 | -$341.36K derived: sum of 2 quarters · filed 2014-12-22 | -$466.59K 10-Q · filed 2014-12-22 | |
| 2013-07-31 | -$179.27K 10-Q · filed 2014-09-29 | -$219.70K 10-Q · filed 2014-09-29 | ||
| 2013-04-30 | -$39.75K 10-Q · filed 2014-07-24 | |||
| 2013-01-31 | -$78.53K 10-K · filed 2014-07-07 |